4//SEC Filing
CARVER JENNIFER 4
Accession 0000920465-19-000030
CIK 0000920465other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:14 PM ET
Size
7.0 KB
Accession
0000920465-19-000030
Insider Transaction Report
Form 4
CARVER JENNIFER
Sr. Vice President, Operations
Transactions
- Award
Common Stock
2019-01-31$5.13/sh+1,260$6,464→ 13,589 total - Award
Stock Option (Right to Buy)
2019-01-31+1,260→ 1,260 totalExercise: $6.04Exp: 2029-01-31→ Common Stock (1,260 underlying)
Footnotes (2)
- [F1]These shares were acquired on 01/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001663163
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:14 PM ET
- Size
- 7.0 KB